4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-18-012113
Chief Medical Officer sold 16,160 shares at $30.00 ($484,800)
- Chief Medical Officer acquired 16,160 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HUMPHREY RACHEL · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-02 | Exercise or conversion : show line 1 in the form | +16,160 | $6.61 | $106,894 | 46,394 | D |
| 2018-03-02 | Sale : show line 2 in the form | −16,160 | $30.00 | $484,800 | 30,234 | D |
| Open-market sales · 16,160 sh · avg $30.00 · $484,800 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-02 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −16,160 | 222,980 | D |
Loading xslF345X03/doc1.xml…